000 | 01548 a2200469 4500 | ||
---|---|---|---|
005 | 20250514031253.0 | ||
264 | 0 | _c20020904 | |
008 | 200209s 0 0 eng d | ||
022 | _a0041-1345 | ||
024 | 7 |
_a10.1016/s0041-1345(01)02668-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGuirado, L | |
245 | 0 | 0 |
_aUse of cytomegalovirus antigenemia as a marker for preemptive treatment. _h[electronic resource] |
260 |
_bTransplantation proceedings _cFeb 2002 |
||
300 |
_a67-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntigens, Viral _xblood |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aCytomegalovirus Infections _xdiagnosis |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aGanciclovir _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
650 | 0 | 4 |
_aPhosphoproteins _xblood |
650 | 0 | 4 |
_aPostoperative Complications _xvirology |
650 | 0 | 4 |
_aViral Matrix Proteins _xblood |
700 | 1 | _aHerreros, M A | |
700 | 1 | _aMuñoz, J M | |
700 | 1 | _aRabella, N | |
700 | 1 | _aFacundo, C | |
700 | 1 | _aAgraz, I | |
700 | 1 | _aDíaz, M | |
700 | 1 | _aDiaz, J M | |
700 | 1 | _aDurán, F | |
700 | 1 | _aSolà, R | |
773 | 0 |
_tTransplantation proceedings _gvol. 34 _gno. 1 _gp. 67-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0041-1345(01)02668-9 _zAvailable from publisher's website |
999 |
_c11861698 _d11861698 |